Aberrant activation of the transcription factor NF-κB, as well as uncontrolled inflammation, has been linked to autoimmune diseases, development and progression of cancer, and neurological disorders like Alzheimer's disease. This evidence concerns the gene NFKB1 and early-onset autosomal dominant Alzheimer disease.